Novo Nordisk, Eli Lilly fall after Trump comments on weight loss drug pricing
GK Partners ApS, a ten percent owner of Nordicus Partners Corp (EXCHANGE:NORD), reported selling shares of common stock worth $482,652, according to a Form 4 filing with the Securities and Exchange Commission. The sales occurred between Feburary 3, 2025 and August 8, 2025, with prices ranging from $0 to $4.0. The stock currently trades at $5.05, within its 52-week range of $1.25 to $10.16. According to InvestingPro analysis, the company’s overall Financial Health Score stands at 1.74, indicating weak fundamentals.
The reported sales included 54,223 shares sold on February 3, 2025 and 7,500 shares sold on the same day at $3.00. On February 19, 2025, the entity sold 49,165 shares. On May 28, 2025, GK Partners ApS disposed of 109,750 shares in a private transaction. Finally, on August 8, 2025, the entity sold 23,300 shares at $2.00.
In addition to the sales, GK Partners ApS acquired shares through purchases and conversions. The company acquired 11,528 shares on February 3, 2025, 10,000 shares on December 19, 2024, 1,504 shares on January 13, 2025, and 11,224 shares on February 13, 2025 as a result of conversion, with prices ranging from $8.91 to $10.0, totaling $213,496. Additionally, the company acquired 10,000 shares on April 22, 2025, 21,000 shares on May 2, 2025, 12,000 shares on May 16, 2025, 6,000 shares on May 22, 2025, 113,095 shares on May 28, 2025, and 7,000 shares on June 16, 2025, for a total of $322,192, with prices ranging from $0 to $5.0. The 49,953 shares acquired on May 28, 2025 were gifted in a private transaction.
Following these transactions, GK Partners ApS directly owns 3,259,025 shares of Nordicus Partners Corp, representing a significant position in the $92.91 million market cap company. InvestingPro analysis suggests the stock is currently undervalued, with additional metrics and insights available to subscribers. Discover more detailed insider trading patterns and Fair Value estimates with an InvestingPro subscription.
In other recent news, Nordicus Partners Corporation has announced changes to its Board of Directors. Henrik Keller has resigned from the board to pursue other interests. In response, the company has expanded its board from three to five members. The new appointees include Torben Jensen, Kim T. Mücke, and Andrew J. Ritter. These changes aim to strengthen the company’s leadership as it continues to focus on assisting life sciences companies in the American market. There were no updates on earnings, revenue, or analyst ratings provided in these recent developments.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.